PUGLIESE, NICOLA RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 5.636
AS - Asia 4.272
EU - Europa 2.230
SA - Sud America 628
AF - Africa 194
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.969
Nazione #
US - Stati Uniti d'America 5.480
SG - Singapore 1.555
CN - Cina 1.139
IT - Italia 725
HK - Hong Kong 623
BR - Brasile 502
SE - Svezia 360
VN - Vietnam 342
DE - Germania 309
GB - Regno Unito 153
FR - Francia 142
BG - Bulgaria 112
IN - India 93
FI - Finlandia 91
JP - Giappone 89
CA - Canada 85
KR - Corea 84
RU - Federazione Russa 72
CI - Costa d'Avorio 62
TR - Turchia 62
BD - Bangladesh 57
AT - Austria 51
AR - Argentina 46
IQ - Iraq 39
MX - Messico 39
NL - Olanda 39
SN - Senegal 39
CZ - Repubblica Ceca 31
PL - Polonia 31
ES - Italia 30
ZA - Sudafrica 23
EC - Ecuador 22
PK - Pakistan 22
SA - Arabia Saudita 21
UA - Ucraina 18
CH - Svizzera 17
CO - Colombia 17
UZ - Uzbekistan 17
ID - Indonesia 15
AZ - Azerbaigian 12
CL - Cile 12
JO - Giordania 12
TN - Tunisia 12
EG - Egitto 10
KZ - Kazakistan 9
MA - Marocco 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
NP - Nepal 8
PS - Palestinian Territory 8
VE - Venezuela 8
ET - Etiopia 7
BE - Belgio 6
KE - Kenya 6
OM - Oman 6
PT - Portogallo 6
PY - Paraguay 6
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
MY - Malesia 5
UY - Uruguay 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
CR - Costa Rica 4
NG - Nigeria 4
PA - Panama 4
PE - Perù 4
SY - Repubblica araba siriana 4
BO - Bolivia 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BJ - Benin 2
BM - Bermuda 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
GY - Guiana 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 12.946
Città #
Singapore 881
Ashburn 720
San Jose 658
Hong Kong 610
Dallas 555
Santa Clara 439
Shanghai 294
Chandler 248
Fairfield 236
Beijing 186
Pisa 177
Los Angeles 157
Boardman 148
Woodbridge 145
Houston 144
New York 143
Munich 126
Hefei 123
Seattle 115
Wilmington 114
Ho Chi Minh City 111
Sofia 110
Florence 102
Cambridge 85
Seoul 83
Tokyo 79
Lucca 74
Ann Arbor 73
Frankfurt am Main 71
Abidjan 62
London 61
Princeton 60
Council Bluffs 58
Hanoi 58
Chicago 57
Lauterbourg 53
Redondo Beach 47
Lawrence 45
Turku 45
São Paulo 40
Medford 39
Buffalo 38
Dakar 38
Vienna 36
Nuremberg 34
Serra 31
Ogden 29
Istanbul 27
Helsinki 26
Dong Ket 25
Salt Lake City 24
Hyderabad 23
Ottawa 23
Livorno 22
Amsterdam 20
Dhaka 20
Orem 20
Warsaw 20
Des Moines 19
Düsseldorf 19
Fuzhou 19
Rome 19
Toronto 19
Brooklyn 18
Chennai 18
Mexico City 17
San Diego 17
Milan 16
Nanjing 16
Phoenix 16
Atlanta 15
Baltimore 15
Boulder 15
Haiphong 15
Lancaster 15
Montreal 15
Olomouc 15
Stockholm 15
Tampa 15
Tashkent 15
Baghdad 14
Denver 14
Johannesburg 14
Lappeenranta 14
Brno 13
Rio de Janeiro 13
San Francisco 13
Belo Horizonte 12
Cascina 12
Da Nang 12
Paris 12
Poplar 12
Zurich 12
Baku 11
Dearborn 11
Guangzhou 11
Quanzhou 11
Amman 10
Quito 10
Bremen 9
Totale 8.691
Nome #
Three-dimensional echographic evaluation of carotid artery disease 248
MicroRNAs distribution in different phenotypes of Aortic Stenosis 224
Critical Limb Ischemia: A Practical Up-To-Date Review 215
The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach 207
The added value of exercise stress echocardiography in patients with heart failure 196
Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients 195
The assessment of pressure-volume relationship during exercise stress echocardiography predicts left ventricular remodeling and eccentric hypertrophy in patients with chronic heart failure 195
Classification and Prognostic Evaluation of Left Ventricular Remodeling in Patients With Asymptomatic Heart Failure. 193
Clinical usefulness of cardio-ankle vascular index, local artery carotid stiffness and global longitudinal strain in subjects with cardiovascular risk factors 193
Circulating mitochondrial DNA signature in cardiometabolic patients 189
Prevalence and Prognostic Impact of Metabolic Syndrome in Asymptomatic (Stage A and B Heart Failure) Patients. 184
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty 176
Translational cardiovascular imaging: A new integrated approach to target myocardial fibrosis turnover in different forms of cardiac remodeling 175
Left ventricular stiffness predicts outcome in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation 172
Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure 172
Review in translational cardiology: Micrornas and myocardial fibrosis in aortic valve stenosis, a deep insight on left ventricular remodeling 170
Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients 169
Persistent congestion, renal dysfunction and inflammatory cytokines in acute heart failure: a prognosis study 167
Micro‑RNA‑21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study 161
Prevalence and determinants of left ventricular diastolic dysfunction in obese subjects and the role of left ventricular global longitudinal strain and mass normalized to height 156
Cardiac Reserve and Exercise Capacity: Insights from Combined Cardiopulmonary and Exercise Echocardiography Stress Testing 153
Characterisation of haemodynamic and metabolic abnormalities in the heart failure spectrum: the role of combined cardiopulmonary and exercise echocardiography stress test 150
Prognostic Role of Sonographic Decongestion in Patients with Acute Heart Failure with Reduced and Preserved Ejection Fraction: A Multicentre Study 145
Novel Techniques, Biomarkers and Molecular Targets to Address Cardiometabolic Diseases 141
Targeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels 140
The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure 137
Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma 135
Incremental value of 3D echocardiography and two-dimensional speckle tracking in the early detection of cardiotoxicity linked to chemotherapy and trastuzumab in patients with HER-2 positive breast cancer 135
Ventricular-Arterial Coupling Derived From Proximal Aortic Stiffness and Aerobic Capacity Across the Heart Failure Spectrum 135
Growth Differentiation Factor 15 in Severe Aortic Valve Stenosis: Relationship with Left Ventricular Remodeling and Frailty 133
Ventricular-arterial coupling derived from proximal aortic stiffness and aerobic capacity across the heart failure spectrum 132
Acute pericarditis in patients receiving coronavirus disease 2019 vaccines: a case series from the community 131
Value of combined cardiopulmonary and echocardiography stress test to characterize the haemodynamic and metabolic responses of patients with heart failure and mid-range ejection fraction 131
Echo-derived peak cardiac power output-to-left ventricular mass with cardiopulmonary exercise testing predicts outcome in patients with heart failure and depressed systolic function 130
Flow dynamic assessment of native mitral valve, mitral valve repair and mitral valve replacement using vector flow mapping intracardiac flow dynamic in mitral valve regurgitation 129
Imaging of Congestion in Cardio-renal Syndrome 128
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol 127
Arterial Hypertension and Cardiopulmonary Function: The Value of a Combined Cardiopulmonary and Echocardiography Stress Test 125
Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment 125
Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: a Prospective Analysis From the VITA Cohort Study 122
null 120
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 119
The impact of ventricular-arterial coupling derived from proximal aortic stiffness on aerobic capacity across the heart failure spectrum 119
Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes 118
Combining cardiopulmonary exercise testing with echocardiography: a multiparametric approach to the cardiovascular and cardiopulmonary systems 117
Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial 117
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing 117
Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study 116
Circadian heart rate fluctuations predict cardiovascular and all-cause mortality in type 2 and type 1 diabetes: a 21-year retrospective longitudinal study 114
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 111
Distinct effects of type 2 diabetes and obesity on cardiopulmonary performance 110
Transthoracic and transoesophageal echocardiography for tricuspid transcatheter edge-to-edge repair: a step-by-step protocol 109
Bio-Humoral and Non-Invasive Haemodynamic Correlates of Renal Venous Flow Patterns across the Heart Failure Spectrum 109
The difficult relationship between uric acid and cardiovascular disease 109
Cardiometabolic Phenotyping in Heart Failure: Differences between Patients with Reduced vs. Preserved Ejection Fraction 108
Integrative assessment of congestion in heart failure using ultrasound imaging 103
The emerging role of endothelial function in cardiovascular oncology 102
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome 101
The relationship between telomere length and putative markers of vascular ageing: A Systematic Review and Meta-analysis 100
Associations of iron deficiency with cardiac function, congestion, exercise capacity and prognosis in heart failure 100
mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis 100
Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications 99
Haemodynamic and metabolic phenotyping of patients with aortic stenosis and preserved ejection fraction: a specific phenotype of heart failure with preserved ejection fraction? 97
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy 97
Predicting the transition to and progression of heart failure with preserved ejection fraction: a weighted risk score using bio-humoural, cardiopulmonary, and echocardiographic stress testing 97
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk 96
Microvascular Ageing Links Metabolic Disease to Age-Related Disorders: The Role of Oxidative Stress and Inflammation in Promoting Microvascular Dysfunction 96
Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function 95
null 95
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 91
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 90
Train the brain to preserve the heart: the link between education and heart failure 90
Diagnostic and Prognostic Value of Lung Ultrasound B-Lines in Acute Heart Failure With Concomitant Pneumonia 89
Myocardial fibrosis and microRNA-21 expression in patients with severe aortic valve stenosis and preserved ejection fraction: a 2D speckle tracking echocardiography, tissutal and plasmatic study 88
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 86
mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis 85
Characterization of hemodynamic and metabolic abnormalities in the heart failure spectrum the role of combined cardiopulmonary and exercise echocardiography stress test 84
The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure 81
INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK 81
Myocardial signal intensity decay after gadolinium injection: A fast and effective method for the diagnosis of cardiac amyloidosis 80
Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study 80
Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial 80
Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease 80
P446 INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK 79
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation 77
Prognostic implication of lung ultrasound in heart failure: a pooled analysis of international cohorts 76
Exercise echocardiography of left ventricular diastolic function in healthy subjects Insights from the RIGHT-NET 76
Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test 76
Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging 75
Renal denervation for the treatment of refractory hypertension: where are we? 75
Prognostic value of lung ultrasound in patients hospitalized for heart disease irrespective of symptoms and ejection fraction 74
Estimation of Aortic Stiffness with Bramwell-Hill Equation: A Comparative Analysis with Carotid-Femoral Pulse Wave Velocity 73
Microvascular Inflammation and Cardiovascular Prevention: The Role of Microcirculation as Earlier Determinant of Cardiovascular Risk 72
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 71
Type 2 diabetes and reduced exercise tolerance: A review of the literature through an integrated physiology approach 70
Digital Ulcers and Ventricular Arrhythmias as Red Flags to Predict Replacement Myocardial Fibrosis in Systemic Sclerosis 69
A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET) 68
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions 68
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 68
Low-dose aspirin therapy for primary prevention of cardiovascular disease: where are we at? 67
Totale 11.951
Categoria #
all - tutte 40.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 0 0 0 0 0 34 55
2021/2022597 7 2 19 40 128 68 20 25 45 29 53 161
2022/2023996 119 157 64 65 64 108 25 84 192 10 97 11
2023/2024873 10 42 102 150 112 99 80 15 9 33 87 134
2024/20253.889 93 119 98 185 277 488 347 154 304 423 518 883
2025/20265.552 407 684 662 619 635 395 731 257 355 695 112 0
Totale 13.335